110 related articles for article (PubMed ID: 27704873)
41. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Kato M; Zhang J; Wang M; Lanting L; Yuan H; Rossi JJ; Natarajan R
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3432-7. PubMed ID: 17360662
[TBL] [Abstract][Full Text] [Related]
42. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
43. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
[TBL] [Abstract][Full Text] [Related]
44. Ameliorative effects of ethanolic leaf extract of Azadirachta indica on renal histologic alterations in streptozotocin-induced diabetic rats.
Oluwole Busayo A; Laura Z; Olufunke Olubusola D; Oluwafunmike Sharon A; Luciana D; Ezekiel Ademola CM
Am J Chin Med; 2011; 39(5):903-16. PubMed ID: 21905281
[TBL] [Abstract][Full Text] [Related]
45. Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy.
Wang J; Duan L; Tian L; Liu J; Wang S; Gao Y; Yang J
Exp Clin Endocrinol Diabetes; 2016 Jul; 124(7):417-23. PubMed ID: 26575121
[TBL] [Abstract][Full Text] [Related]
46. Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs.
Fiorentino L; Cavalera M; Mavilio M; Conserva F; Menghini R; Gesualdo L; Federici M
Acta Diabetol; 2013 Dec; 50(6):965-9. PubMed ID: 23797704
[TBL] [Abstract][Full Text] [Related]
47. The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
Qing-Hua G; Ju-Ming L; Chang-Yu P; Zhao-Hui L; Xiao-Man Z; Yi-Ming M
J Diabetes Complications; 2008; 22(6):408-12. PubMed ID: 18413157
[TBL] [Abstract][Full Text] [Related]
48. A single-cell profile reveals the transcriptional regulation responded for Abelmoschus manihot (L.) treatment in diabetic kidney disease.
Wu C; Tang H; Cui X; Li N; Fei J; Ge H; Wu L; Wu J; Gu HF
Phytomedicine; 2024 Jul; 130():155642. PubMed ID: 38759315
[TBL] [Abstract][Full Text] [Related]
49. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
Li JJ; Lee SH; Kim DK; Jin R; Jung DS; Kwak SJ; Kim SH; Han SH; Lee JE; Moon SJ; Ryu DR; Yoo TH; Han DS; Kang SW
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F200-9. PubMed ID: 19369290
[TBL] [Abstract][Full Text] [Related]
50. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
Takamiya Y; Fukami K; Yamagishi S; Kaida Y; Nakayama Y; Obara N; Iwatani R; Ando R; Koike K; Matsui T; Nishino Y; Ueda S; Cooper ME; Okuda S
Nephrol Dial Transplant; 2013 Jan; 28(1):55-62. PubMed ID: 23028104
[TBL] [Abstract][Full Text] [Related]
51. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
[TBL] [Abstract][Full Text] [Related]
52. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?
McLennan SV; Kelly DJ; Schache M; Waltham M; Dy V; Langham RG; Yue DK; Gilbert RE
Kidney Int; 2007 Aug; 72(4):481-8. PubMed ID: 17554258
[TBL] [Abstract][Full Text] [Related]
53. Abelmoschus esculentus fractions potently inhibited the pathogenic targets associated with diabetic renal epithelial to mesenchymal transition.
Peng CH; Chyau CC; Wang CJ; Lin HT; Huang CN; Ker YB
Food Funct; 2016 Feb; 7(2):728-40. PubMed ID: 26787242
[TBL] [Abstract][Full Text] [Related]
54. Multitargeted inhibition of hepatic fibrosis in chronic iron-overloaded mice by Salvia miltiorrhiza.
Zhang Y; Zhang Y; Xie Y; Gao Y; Ma J; Yuan J; Li J; Wang J; Li L; Zhang J; Chu L
J Ethnopharmacol; 2013 Jul; 148(2):671-81. PubMed ID: 23707206
[TBL] [Abstract][Full Text] [Related]
55. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
[TBL] [Abstract][Full Text] [Related]
56. Pentamethylquercetin ameliorates fibrosis in diabetic Goto-Kakizaki rat kidneys and mesangial cells with suppression of TGF-β/Smads signaling.
Xin X; Li XH; Wu JZ; Chen KH; Liu Y; Nie CJ; Hu Y; Jin MW
Eur J Pharmacol; 2013 Aug; 713(1-3):6-15. PubMed ID: 23665496
[TBL] [Abstract][Full Text] [Related]
57. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration.
Lv SS; Liu G; Wang JP; Wang WW; Cheng J; Sun AL; Liu HY; Nie HB; Su MR; Guan GJ
Int Immunopharmacol; 2013 Oct; 17(2):275-82. PubMed ID: 23791972
[TBL] [Abstract][Full Text] [Related]
59. Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals.
Chin HJ; Fu YY; Ahn JM; Na KY; Kim YS; Kim S; Chae DW
Nephrol Dial Transplant; 2010 May; 25(5):1450-7. PubMed ID: 20042400
[TBL] [Abstract][Full Text] [Related]
60. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
